Activ Surgical, Inc. news
BOSTON — May 24, 2022 — Activ Surgical™, a digital surgery pioneer, today announced the successful completion of an Institutional Review Board (IRB) study using its ActivSight™ intraoperative imaging module at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo (UB) in New York. The 40-patient study was led by principal investigator
London, UK and Boston, MA – March 22, 2022 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced that its venture capital arm, Hikma Ventures has led an $15 million USD round of financing for Activ Surgical,
Today marks yet another milestone in Activ Surgical’s history as we announce that the company was issued its third patent from the United States Patent and Trademark Office (USPTO) for our ActivSightTM interoperable imaging module. The ActivSight module is designed to interface with existing vision systems to enable surgeons to view in real-time critical physiological structures and functions, like blood flow, that cannot be seen with the naked eye
All of us at Activ Surgical are thrilled to announce that the company was issued its second patent from the United States Patent and Trademark Office (USPTO) related to our ActivSightTM imaging module on November 23, 2021. This patent–U.S. Patent No. 11,179,218 B2–demonstrates our potential to build on the current version of the tool, including the addition of multimodal sensing to robotic surgical vision systems.
The
BOSTON — December 6, 2021 — Activ Surgical, Inc., a digital surgery pioneer, today announced that it has been named the “Inno on Fire Blazer” in the Health and Medtech category as part of BostInno’s 2021 Inno on Fire Aw